Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Non-Radiographic Axial Spondyloarthritis
NCT01258738Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2011
- Primary completion
- Nov 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 14
01
Overview
A Phase 3 trial of etanercept in non-radiographic axial spondyloarthritis (nr-axSpA), sponsored by Pfizer. Started Feb 2011; status: completed.
02
Drugs
etanercept
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NCT01258738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01258738.